ERNA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Eterna Therapeutics Inc

NASDAQ | ERNA

1.18

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$9.55M

Market Cap

-

P/E Ratio

-17.76

EPS

$22.35

52 Week High

$1.17

52 Week Low

HEALTHCARE

Sector

ERNA Chart

Recent Chart
Price Action

ERNA Technicals

Tags:

ERNA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $486K
Total Revenue $582K
Cost Of Revenue $96K
Costof Goods And Services Sold $96K
Operating Income -$16M
Selling General And Administrative $13M
Research And Development $4.6M
Operating Expenses $16M
Investment Income Net -
Net Interest Income -$6.5M
Interest Income $249K
Interest Expense $6.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$45M
Income Tax Expense $30K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$38M
Ebitda -$36M
Net Income -$45M

Revenue & Profitability

Earnings Performance

ERNA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $5.3M
Total Current Assets $2.4M
Cash And Cash Equivalents At Carrying Value $1.7M
Cash And Short Term Investments $1.7M
Inventory -
Current Net Receivables $437K
Total Non Current Assets $2.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill $2M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $186K
Other Non Current Assets -
Total Liabilities $3.6M
Total Current Liabilities $2.9M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $207K
Total Non Current Liabilities $630K
Capital Lease Obligations $684K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $684K
Other Current Liabilities $1M
Other Non Current Liabilities $152K
Total Shareholder Equity $1.7M
Treasury Stock -
Retained Earnings -$232M
Common Stock $257K
Common Stock Shares Outstanding $28M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$16M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $369K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$365K
Cashflow From Financing $6.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $16K
Dividend Payout Common Stock $16K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$45M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $486K
Total Revenue $582K
Cost Of Revenue $96K
Costof Goods And Services Sold $96K
Operating Income -$16M
Selling General And Administrative $13M
Research And Development $4.6M
Operating Expenses $16M
Investment Income Net -
Net Interest Income -$6.5M
Interest Income $249K
Interest Expense $6.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$45M
Income Tax Expense $30K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$38M
Ebitda -$36M
Net Income -$45M

ERNA News

ERNA Profile

Eterna Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Eterna Therapeutics Inc., a clinical-stage biopharmaceutical company based in Brooklyn, New York, is at the forefront of developing innovative therapies aimed at transforming the treatment landscape for cancer patients. The company focuses on leveraging its advanced technology platforms to create next-generation immunotherapies, addressing significant unmet medical needs in oncology. With a strong commitment to clinical research and collaboration, Eterna is poised to drive breakthroughs in patient care and add substantial value to the biopharmaceutical sector.

ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PLTR
-1.11%
$168.36
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-0.98%
$9.02
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PLTR
-1.11%
$168.36
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-0.98%
$9.02
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.